COMP <GO>
MESO vs VCEL // EV/EBITDA & P/E VALUATION
Mesoblast Limited (NASDAQ) VS. Vericel Corporation (NASDAQ) • 15-METRIC TALLY: MESO 1
— VCEL 1
■ METRIC PARITY
LAST: $15.67 (+17.03%) • MKT CAP: $2.04B
valuation
—
LAST: $42.91 (+4.43%) • MKT CAP: $2.20B
valuation
61.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MESO VS. VCEL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MESO | VCEL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 3.40% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 61.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 1.13% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 4.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 6.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 16.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 9.94 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 8/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.6 | 46.2 | +12.47 | MESO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 111.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.04B | $2.20B | -$158.8M | VCEL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MESO REV | VCEL REV | MESO GROSS % | VCEL GROSS % | MESO FCF | VCEL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $276.3M | — | 74.4% | — | $24.7M |
| FY 2024 | — | $237.2M | — | 72.6% | — | -$5.8M |
| FY 2023 | — | $197.5M | — | — | — | $35.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MESO // BETA —
VCEL // BETA —